Monte Rosa Therapeutics
GLUE
#7806
Rank
A$0.40 B
Marketcap
$6.53
Share price
1.54%
Change (1 day)
-39.19%
Change (1 year)

Monte Rosa Therapeutics (GLUE) - Cash on Hand

Cash on Hand as of December 2024 : A$0.61 Billion

According to Monte Rosa Therapeutics's latest financial reports the company has A$0.61 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monte Rosa Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.59 B75.39%
2023-12-31A$0.34 B-11.67%
2022-12-31A$0.38 B-19.09%
2021-12-31A$0.47 B780.24%
2020-12-31A$54.22 M533.34%
2019-12-31A$8.56 M